PAI
Palo Alto Investors Portfolio holdings
AUM $470M
1-Year Return
2.57%
This Quarter Return
+5.34%
1 Year Return
+2.57%
3 Year Return
+93.77%
5 Year Return
+190.64%
10 Year Return
+955.02%
AUM
$2.47B
AUM Growth
-$28.4M
(-1.1%)
Cap. Flow
-$71.6M
Cap. Flow
% of AUM
-2.9%
Top 10 Holdings %
Top 10 Hldgs %
69.94%
Holding
36
New
–
Increased
10
Reduced
2
Closed
–
Top Buys
| 1 |
CLVS
Clovis Oncology, Inc.
CLVS
|
+$7.25M |
| 2 |
IMMU
Immunomedics Inc
IMMU
|
+$4.38M |
| 3 |
CELG
Celgene Corp
CELG
|
+$3.08M |
| 4 |
Insmed
INSM
|
+$2.44M |
| 5 |
Amicus Therapeutics
FOLD
|
+$2.39M |
Top Sells
| 1 |
ABMD
Abiomed Inc
ABMD
|
+$81.6M |
| 2 |
Align Technology
ALGN
|
+$14.4M |
Sector Composition
| 1 | Healthcare | 91.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Rigel Pharmaceuticals
RIGL
$635M
| $12.7M | 0.51% |
396,609
| – | – |
|
|
DRNA
27
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $7.64M | 0.31% |
500,913
| – | – |
|
|
ALIM
28
DELISTED
Alimera Sciences, Inc.
ALIM
| $2.95M | 0.12% |
200,920
| – | – |
|
|
VIRX
29
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $2.33M | 0.09% |
33,214
| – | – |
|
|
ZGNX
30
DELISTED
Zogenix, Inc.
ZGNX
| $1.46M | 0.06% |
29,500
| – | – |
|
31
Cytokinetics
CYTK
$6.07B
| $1.22M | 0.05% |
123,686
| – | – |
|
|
TRVN
32
DELISTED
Trevena, Inc.
TRVN
| $724K | 0.03% |
546
| – | – |
|
|
SPHS
33
DELISTED
Sophiris Bio, Inc.
SPHS
| $689K | 0.03% |
247,000
| – | – |
|
|
ACGN
34
DELISTED
Aceragen, Inc. Common Stock
ACGN
| $686K | 0.03% |
4,537
| – | – |
|
|
MLNT
35
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
| $200K | 0.01% |
10,138
| – | – |
|
36
Ocugen
OCGN
$365M
| $165K | 0.01% |
5,049
| – | – |
|